Organization | Saint Francis Memorial Hospital

Saint Francis Memorial Hospital Report issue

Academic/Hospital Phase 1 Phase 2 Phase 4

Organization Overview

First Clinical Trial

1999

NCT00014092

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2022

Timeline

NOW

Now

Alternative names

Saint Francis Memorial Hospital

Active Ingredients

Drugs in Phase 4 Trials (4)

azithromycin (zithromax) (1 trial)

doxycycline (vibramycin) (1 trial)

hydroxychloroquine (plaquenil) (1 trial)

zinc sulfate (1 trial)

Drugs in Phase 2 Trials (5)

aldesleukin (Proleukin) (1 trial)

as1411 (1 trial)

interferon alpha-2b (Intron-A) (1 trial)

sargramostim (leukine) (1 trial)

temozolomide (temodar) (1 trial)

Drugs in Phase 1 Trials (1)

sildenafil (viagra) (1 trial)

Drugs in Other Trials (3)

clopidogrel (plavix) (1 trial)

prasugrel (effient) (1 trial)

thienoyridine (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Carcinoma (Phase 2)

Carcinoma, Renal Cell (Phase 2)

Melanoma (Phase 2)

Overview

Highest Phase: Phase 4
# of Trials: 5
# of Trial APIs: 13